C
CIN Terminal
Cannabis Investor News
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch

MSO Stocks: US Multi-State Cannabis Operators

The reference source for MSO stocks: US multi-state cannabis operators with retail, cultivation, and processing footprints across multiple state cannabis markets. Live prices, analyst ratings, EBITDA multiples, and daily news for every publicly traded MSO.

What is an MSO stock

MSO stands for multi-state operator: a US cannabis company with licensed cultivation, processing, or retail operations in more than one state cannabis market. Because cannabis remains federally illegal in the US, MSOs cannot list on NYSE or Nasdaq and instead trade on the OTC Markets (US) and the Canadian Securities Exchange (CSE). MSO stocks are the largest US-listed cannabis exposure available to public equity investors.

Major MSO stocks CIN covers

  • Green Thumb Industries (GTBIF): Vertically integrated MSO with operations in 15+ states, known for Rise dispensaries
  • Trulieve Cannabis (TCNNF): Florida-focused MSO with the largest US retail footprint
  • Curaleaf Holdings (CURLF): Diversified MSO with operations in 17+ states, largest by revenue
  • Verano Holdings (VRNOF): Vertically integrated MSO with strong Illinois and Florida presence
  • Cresco Labs (CRLBF): MSO with the Sunnyside retail brand and wholesale strength
  • Ascend Wellness (AAWH): East-coast focused MSO
  • Jushi Holdings (JUSHF): MSO with Virginia, Pennsylvania, and Illinois operations
  • Columbia Care, TerrAscend, Ayr Wellness, Planet 13: Additional MSOs with regional footprints

For live prices and dashboards on each MSO stock, use the stocks directory. For the sector-level MSO exposure, see cannabis ETFs: MSOS is the largest MSO-focused ETF.

MSO stock financials and analysis

MSO stocks are analyzed on adjusted EBITDA, revenue growth, retail unit economics, and state-market share. CIN tracks EBITDA multiples across the MSO cohort and publishes valuation comparisons on the financials dashboard. Analyst ratings and price targets for MSO stocks are aggregated on the analyst coverage page.

Regulatory catalysts (DEA rescheduling, SAFE Banking, state legalization) disproportionately affect MSO stock prices because MSOs are the most direct beneficiaries of US federal reform. CIN tracks every regulatory milestone through the macro dashboard and daily brief.

Track every MSO stock in one place

Live prices, analyst ratings, and financials for every US multi-state cannabis operator, updated every trading minute.

Open the MSO dashboard →

Frequently asked questions

What does MSO stand for in cannabis?

MSO stands for multi-state operator: a US cannabis company that holds licenses in more than one state cannabis market. Most MSOs are vertically integrated, meaning they own cultivation, processing, and retail across the states they operate in. Because cannabis remains federally illegal in the US, MSOs trade on OTC Markets and the Canadian Securities Exchange rather than NYSE or Nasdaq.

What are the largest MSO stocks?

The largest cannabis MSO stocks by market cap and revenue are Curaleaf Holdings (CURLF), Green Thumb Industries (GTBIF), Trulieve Cannabis (TCNNF), Verano Holdings (VRNOF), and Cresco Labs (CRLBF). Other significant MSO stocks include Ascend Wellness (AAWH), Jushi Holdings (JUSHF), TerrAscend (TSNDF), Columbia Care, and Planet 13. Live rankings for the full MSO cohort are on the CIN markets dashboard.

Why don't MSO stocks trade on NYSE or Nasdaq?

Cannabis is a Schedule I controlled substance under US federal law. NYSE and Nasdaq are federally regulated by the SEC and do not permit direct listings of companies that plant-touch federally illegal substances. MSO stocks therefore list on OTC Markets in the US and on the Canadian Securities Exchange, where the regulatory framework accommodates cannabis issuers. Federal rescheduling could change this.

Are MSO stocks profitable?

MSO stocks vary widely in profitability. The larger MSOs (Green Thumb, Trulieve) have consistently generated positive adjusted EBITDA and free cash flow. Smaller MSOs have struggled with Section 280E tax drag, high capital costs, and state-market competition. Investors should track adjusted EBITDA, EBITDA margin, and cash on hand quarter over quarter. CIN publishes a full MSO EBITDA comparison on the financials dashboard.

What is Section 280E and how does it affect MSO stocks?

Section 280E of the US Internal Revenue Code disallows normal business tax deductions for entities selling federally illegal substances. That means MSO stocks pay federal tax on their gross profits (revenue minus cost of goods sold) rather than net profits. Effective tax rates for cannabis operators can exceed 60 to 70 percent. Federal rescheduling of cannabis from Schedule I to Schedule III would eliminate Section 280E and materially expand MSO free cash flow.

What is the best way to invest in MSO stocks?

Direct investment requires a broker that supports OTC MSO trading (many major US brokers restrict this). Alternatively, the AdvisorShares Pure US Cannabis ETF (MSOS) uses total return swaps to give investors synthetic MSO exposure through a Nasdaq-listed vehicle. Both approaches carry risk: individual MSO stocks are volatile and thinly traded, while MSOS carries swap counterparty risk and fees tied to interest rates. See the CIN ETF hub for MSOS holdings and analysis.

How does CIN cover MSO stocks?

CIN tracks every publicly traded cannabis MSO with a dedicated ticker page: live prices, market cap, analyst ratings, price targets, valuation multiples, recent SEC filings, and every brief mention. Sector-level MSO analysis publishes in the daily briefs, weekly chart book, and thematic Insights articles. Regulatory catalysts affecting MSOs (DEA rescheduling, SAFE Banking, state legalization) are tracked on the macro dashboard.

Related coverage

Every CIN coverage module in one grid. Each is its own destination with live data and daily updates from the CIN Research Desk.

Cannabis Investor News, CIN Editorial Desk. Coverage universe: 494 publicly traded cannabis equities across 10 regions and 16 exchanges. Methodology: methodology. Editorial standards: editorial standards.